GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$76.68
+0.00% today
Updated 2026-06-05
Market cap
$10.91B
P/E ratio
18.78
P/S ratio
3.52x
EPS (TTM)
$4.28
Dividend yield
—
52W range
$52 – $101
Volume
1.5M
Globus Medical (GMED) Insider transactions
Net insider activity
Net buying (395,862 shares)
Buy transactions
48
Sell transactions
52
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-25 | HULLER, KELLY | EVP, GC, Corporate Secretary | Sale | 20,000 | — | — |
| 2026-02-25 | HULLER, KELLY | EVP, GC, Corporate Secretary | Buy | 20,000 | $43.58 | $871600.00 |
| 2026-02-12 | HULLER, KELLY | EVP, GC, Corporate Secretary | Sale | 10,000 | — | — |
| 2026-02-12 | HULLER, KELLY | EVP, GC, Corporate Secretary | Buy | 10,000 | $45.64 | $456400.00 |
| 2026-01-21 | ZARRILLI, STEPHEN T | Director | Buy | 15,000 | — | — |
| 2026-01-21 | WOLTERMAN, DAN | Director | Buy | 15,000 | — | — |
| 2026-01-21 | TOBIN, JAMES R | Director | Buy | 15,000 | — | — |
| 2026-01-21 | RHOADS, ANN D | Director | Buy | 15,000 | — | — |
| 2026-01-21 | PFEIL, KEITH W | Director, President, CEO | Buy | 100,000 | — | — |
| 2026-01-21 | PAUL, DAVID C | Director, Executive Chairman, 10% Owner | Buy | 100,000 | — | — |
| 2026-01-21 | NORWALK, LESLIE V | Director | Buy | 15,000 | — | — |
| 2026-01-21 | LEMAITRE, DAN | Director | Buy | 15,000 | — | — |
| 2026-01-21 | KLINE, KYLE | Senior Vice President, CFO | Buy | 30,000 | — | — |
| 2026-01-21 | HULLER, KELLY | EVP, GC, Corporate Secretary | Buy | 40,000 | — | — |
| 2026-01-21 | DOUGLAS, ROBERT ANDREW | Director | Buy | 15,000 | — | — |
| 2026-01-21 | DEFORD, JOHN A | Director | Buy | 15,000 | — | — |
| 2026-01-21 | DAVIDAR, DAVID D | Director | Buy | 15,000 | — | — |
| 2026-01-08 | NORWALK, LESLIE V | Director | Sale | 2,000 | $101.10 | $202200.00 |
| 2026-01-08 | KLINE, KYLE | Senior Vice President, CFO | Sale | 3,594 | — | — |
| 2026-01-08 | KLINE, KYLE | Senior Vice President, CFO | Sale | 3,594 | $101.10 | $363353.40 |
| 2025-12-12 | NORWALK, LESLIE V | Director | Sale | 4,000 | $88.85 | $355400.00 |
| 2025-12-08 | PAUL, DAVID C | Director, Executive Chairman, 10% Owner | Sale | 34,375 | — | — |
| 2025-12-08 | PAUL, DAVID C | Director, Executive Chairman, 10% Owner | Buy | 34,375 | $25.52 | $877250.00 |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Sale | 5,000 | — | — |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Sale | 4,896 | — | — |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Sale | 3,646 | — | — |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Sale | 18,542 | $90.00 | $1.67M |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Buy | 5,000 | $56.43 | $282150.00 |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Buy | 4,896 | $63.68 | $311777.28 |
| 2025-12-01 | KLINE, KYLE | Senior Vice President, CFO | Buy | 3,646 | $53.14 | $193748.44 |
| 2025-11-25 | HULLER, KELLY | SVP, GC, Corporate Secretary | Sale | 7,500 | — | — |
| 2025-11-25 | HULLER, KELLY | SVP, GC, Corporate Secretary | Buy | 7,500 | $25.96 | $194700.00 |
| 2025-11-12 | DAVIDAR, DAVID D | Director | Sale | 25,000 | — | — |
| 2025-11-12 | DAVIDAR, DAVID D | Director | Sale | 25,000 | $86.00 | $2.15M |
| 2025-11-11 | ZARRILLI, STEPHEN T | Director | Sale | 25,000 | — | — |
| 2025-11-11 | ZARRILLI, STEPHEN T | Director | Buy | 25,000 | $44.14 | $1.10M |
| 2025-11-10 | RHOADS, ANN D | Director | Sale | 2,000 | $85.00 | $170000.00 |
| 2025-11-07 | RHOADS, ANN D | Director | Sale | 8,000 | $81.00 | $648000.00 |
| 2025-09-15 | RHOADS, ANN D | Director | Sale | 10,000 | $58.46 | $584600.00 |
| 2025-07-18 | PFEIL, KEITH W | Director, President, CEO | Buy | 40,000 | — | — |
| 2025-07-18 | KLINE, KYLE | Senior Vice President, CFO | Buy | 20,909 | — | — |
| 2025-02-28 | RHOADS, ANN D | Director | Sale | 7,500 | $78.68 | $590100.00 |
| 2025-01-23 | ZARRILLI, STEPHEN T | Director | Buy | 15,000 | — | — |
| 2025-01-23 | WOLTERMAN, DAN | Director | Buy | 15,000 | — | — |
| 2025-01-23 | TOBIN, JAMES R | Director | Buy | 15,000 | — | — |
| 2025-01-23 | SCAVILLA, DANIEL T | Director, President, CEO | Buy | 140,000 | — | — |
| 2025-01-23 | RHOADS, ANN D | Director | Buy | 15,000 | — | — |
| 2025-01-23 | PFEIL, KEITH W | COO, CFO | Buy | 60,000 | — | — |
| 2025-01-23 | PAUL, DAVID C | Director, Executive Chairman, 10% Owner | Buy | 75,000 | — | — |
| 2025-01-23 | NORWALK, LESLIE V | Director | Buy | 15,000 | — | — |
| 2025-01-23 | LEMAITRE, DAN | Director | Buy | 15,000 | — | — |
| 2025-01-23 | HULLER, KELLY | SVP, GC, Corporate Secretary | Buy | 40,000 | — | — |
| 2025-01-23 | DOUGLAS, ROBERT ANDREW | Director | Buy | 15,000 | — | — |
| 2025-01-23 | DEFORD, JOHN A | Director | Buy | 15,000 | — | — |
| 2025-01-23 | DAVIDAR, DAVID D | Director | Buy | 15,000 | — | — |
| 2025-01-10 | PFEIL, KEITH W | COO, CFO | Sale | 8,334 | — | — |
| 2025-01-10 | PFEIL, KEITH W | COO, CFO | Sale | 5,833 | — | — |
| 2025-01-10 | PFEIL, KEITH W | COO, CFO | Sale | 12,501 | $88.17 | $1.10M |
| 2025-01-10 | PFEIL, KEITH W | COO, CFO | Buy | 8,334 | $53.27 | $443952.18 |
| 2025-01-10 | PFEIL, KEITH W | COO, CFO | Buy | 5,833 | $49.65 | $289608.45 |
| 2025-01-10 | PFEIL, KEITH W | COO, CFO | Sale | 1,666 | $89.17 | $148557.22 |
| 2025-01-02 | DAVIDAR, DAVID D | Director | Sale | 6,100 | — | — |
| 2024-12-02 | HULLER, KELLY | SVP, GC, Corporate Secretary | Sale | 2,500 | — | — |
| 2024-12-02 | HULLER, KELLY | SVP, GC, Corporate Secretary | Sale | 2,500 | $87.00 | $217501.50 |
| 2024-11-22 | LEMAITRE, DAN | Director | Sale | 1,097 | — | — |
| 2024-11-22 | LEMAITRE, DAN | Director | Sale | 1,097 | $85.02 | $93263.21 |
| 2024-11-22 | DAVIDAR, DAVID D | Director | Sale | 6,766 | $85.00 | $575135.03 |
| 2024-11-22 | DAVIDAR, DAVID D | Director | Sale | 6,746 | $85.00 | $573434.96 |
| 2024-11-21 | SCAVILLA, DANIEL T | Director, President, CEO | Sale | 80,000 | — | — |
| 2024-11-21 | SCAVILLA, DANIEL T | Director, President, CEO | Sale | 50,000 | — | — |
| 2024-11-21 | SCAVILLA, DANIEL T | Director, President, CEO | Sale | 130,000 | $85.00 | $11.05M |
| 2024-11-21 | SCAVILLA, DANIEL T | Director, President, CEO | Buy | 80,000 | $43.58 | $3.49M |
| 2024-11-21 | SCAVILLA, DANIEL T | Director, President, CEO | Buy | 50,000 | $43.77 | $2.19M |
| 2024-11-21 | LEMAITRE, DAN | Director | Sale | 13,278 | — | — |
| 2024-11-21 | LEMAITRE, DAN | Director | Sale | 13,278 | $85.00 | $1.13M |
| 2024-11-21 | DAVIDAR, DAVID D | Director | Sale | 13,254 | $85.00 | $1.13M |
| 2024-11-21 | DAVIDAR, DAVID D | Director | Sale | 13,234 | $85.00 | $1.12M |
| 2024-11-15 | PAUL, DAVID C | Director, Executive Chairman, 10% Owner | Sale | 26,042 | — | — |
| 2024-11-15 | PAUL, DAVID C | Director, Executive Chairman, 10% Owner | Buy | 26,042 | $24.10 | $627612.20 |
| 2024-11-06 | SCAVILLA, DANIEL T | Director, President, CEO | Buy | 30,000 | — | — |
| 2024-11-06 | SCAVILLA, DANIEL T | Director, President, CEO | Sale | 60,000 | $80.02 | $4.80M |
| 2024-11-06 | SCAVILLA, DANIEL T | Director, President, CEO | Buy | 30,000 | $43.77 | $1.31M |
| 2024-11-06 | HULLER, KELLY | SVP, GC, Corporate Secretary | Sale | 5,000 | — | — |
| 2024-11-06 | HULLER, KELLY | SVP, GC, Corporate Secretary | Buy | 5,000 | $24.21 | $121050.00 |
| 2024-11-06 | HULLER, KELLY | SVP, GC, Corporate Secretary | Sale | 2,500 | $80.02 | $200050.00 |
| 2024-10-16 | HULLER, KELLY | SVP, GC, Corporate Secretary | Sale | 7,500 | — | — |
| 2024-10-16 | HULLER, KELLY | SVP, GC, Corporate Secretary | Buy | 7,500 | $25.80 | $193500.00 |
| 2024-10-16 | DAVIDAR, DAVID D | Director | Sale | 30,000 | $75.04 | $2.25M |
| 2024-10-16 | DAVIDAR, DAVID D | Director | Sale | 20,000 | $75.03 | $1.50M |
| 2024-09-13 | RHOADS, ANN D | Director | Sale | 20,000 | — | — |
| 2024-09-13 | RHOADS, ANN D | Director | Sale | 15,000 | — | — |
| 2024-09-13 | RHOADS, ANN D | Director | Buy | 20,000 | $25.52 | $510400.00 |
| 2024-09-13 | RHOADS, ANN D | Director | Buy | 15,000 | $24.10 | $361500.00 |
| 2024-09-13 | DAVIDAR, DAVID D | Director | Sale | 25,000 | — | — |
| 2024-09-13 | DAVIDAR, DAVID D | Director | Sale | 25,000 | $70.46 | $1.76M |
| 2024-07-11 | NORWALK, LESLIE V | Director | Sale | 1,000 | $70.00 | $70000.00 |
| 2024-05-10 | LEMAITRE, DAN | Director | Sale | 17,500 | — | — |
| 2024-05-10 | LEMAITRE, DAN | Director | Sale | 63,300 | $64.61 | $4.09M |
| 2024-05-10 | LEMAITRE, DAN | Director | Buy | 17,500 | $43.58 | $762650.00 |
| 2024-05-08 | DAVIDAR, DAVID D | Director | Sale | 20,000 | $65.00 | $1.30M |
Frequently asked questions
Are GMED insiders buying or selling?
Over the transactions on record, GMED insiders have been net sellers, with about $39.85M in stock sold across 52 sales, against 19 open-market purchases.
Does insider selling at GMED mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which GMED insiders are selling the most?
Recent selling is concentrated in a few names. SCAVILLA, DANIEL T accounts for the largest share on record, with about $15.85M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.